SHOPPING CART
REGISTER
LOGIN
SEARCH

Diagnostic Testing & Technology Report

February 2010

New Payers Sign On to McKesson’s Molecular Dx Criteria Analysis System

New York-based MVP Health Care and Blue Cross of Idaho are the two latest payers using the InterQual Molecular Diagnostics Criteria system, from McKesson’s Advanced Diagnostics Management Division (ADM), which uses reviews of evidence-based medicine to assess appropriateness and utilization patterns in making coverage decisions.

Login | Subscribe

February 2010 - Table of Contents

DTTR February 2010 (Full PDF Issue)

Genomic Health Revenue Climbs 35% in 2009

Quidel to Acquire Diagnostic Hybrids for $130M

Predictive Biosciences Buys CLIA-Certified Anatomic Pathology Lab

ADA Issues Updated Recommendations for Diabetes Testing

Cepheid Receives FDA Emergency Use Authorization for H1N1 Flu Test

Philips and bioMerieux to Jointly Develop Point-of-Care Tests

Abbott Receives CE Mark for Ovarian Cancer Test

Inside the Diagnostic Industry: Genomic Health Looks to Replicate Its Oncotype DX Across Multiple Cancers, Continents

Seeing Strong Growth in Clinical Applications, Life Technologies Expands Molecular Diagnostics Franchise

Quest Diagnostics Introduces Lab-Developed Test for Colorectal Cancer

Genetic Variant Linked to Aggressive Form of Prostate Cancer

New Payers Sign On to McKesson�s Molecular Dx Criteria Analysis System

Medicare Spending Up, Even as National Health Spending Slows

IVD Stocks Rose 31% in 2009 Led by Inverness, Clinical Data, Affy

G2 Insider (February 2010)

Diagnostic Testing & Technology Report is part of...

Focus Areas	Product Group
G2 Reports Medical Lab Management	Newsletters